Literature DB >> 25144571

Experimental colitis is exacerbated by concomitant infection with Mycobacterium avium ssp. paratuberculosis.

Abdulhadi Suwandi1, Imke Bargen, Bishnudeo Roy, Marina C Pils, Martina Krey, Susanne Zur Lage, Tina Basler, Manfred Rohde, Christine S Falk, Mathias W Hornef, Ralph Goethe, Siegfried Weiss.   

Abstract

BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disorder of the human gastrointestinal tract. Although genetic, immunological, environmental, and bacterial factors have been implicated, the pathogenesis is incompletely understood. The histopathological appearance of CD strikingly resembles Johne's disease, a ruminant inflammatory bowel disease, caused by Mycobacterium avium ssp. paratuberculosis (MAP), but a causative role of MAP in CD has not been established. In this work, we hypothesized that MAP might exacerbate an already existing intestinal disease.
METHODS: We combined dextran sulfate sodium (DSS)-induced colitis with MAP infection in mice and monitored the immune response and bacterial count in different organs.
RESULTS: An increased size of liver and spleen was observed in DSS-treated and MAP-infected animals (DSS + MAP) as compared with DSS-treated uninfected (DSS + PBS) mice. Similarly, DSS treatment increased the number and size of MAP-induced liver granulomas and enhanced the MAP counts in enteric tissue. MAP infection in turn delayed the mucosal healing of DSS-induced tissue damage. Finally, high numbers of MAP were found in mesenteric fat tissue causing large granuloma and necrotic regions.
CONCLUSIONS: Taken together, we present an in vivo model to study the role of MAP infection in CD. Our results confirm the hypothesis that MAP is able to exacerbate existing intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144571     DOI: 10.1097/MIB.0000000000000157

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  5 in total

1.  cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.

Authors:  Nanthapon Ruangkiattikul; Andreas Nerlich; Ketema Abdissa; Stefan Lienenklaus; Abdulhadi Suwandi; Nina Janze; Kristin Laarmann; Julia Spanier; Ulrich Kalinke; Siegfried Weiss; Ralph Goethe
Journal:  Virulence       Date:  2017-04-19       Impact factor: 5.882

2.  FurA contributes to the oxidative stress response regulation of Mycobacterium avium ssp. paratuberculosis.

Authors:  Elke Eckelt; Thorsten Meißner; Jochen Meens; Kristin Laarmann; Andreas Nerlich; Michael Jarek; Siegfried Weiss; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Microbiol       Date:  2015-02-06       Impact factor: 5.640

3.  CD4 T Cell Dependent Colitis Exacerbation Following Re-Exposure of Mycobacterium avium ssp. paratuberculosis.

Authors:  Abdulhadi Suwandi; Imke Bargen; Marina C Pils; Martina Krey; Susanne Zur Lage; Anurag K Singh; Tina Basler; Christine S Falk; Ursula Seidler; Mathias W Hornef; Ralph Goethe; Siegfried Weiss
Journal:  Front Cell Infect Microbiol       Date:  2017-03-16       Impact factor: 5.293

4.  Relevance of inducible nitric oxide synthase for immune control of Mycobacterium avium subspecies paratuberculosis infection in mice.

Authors:  Ketema Abdissa; Nanthapon Ruangkiattikul; Wiebke Ahrend; Andreas Nerlich; Andreas Beineke; Kristin Laarmann; Nina Janze; Ulrike Lobermeyer; Abdulhadi Suwandi; Christine Falk; Ulrike Schleicher; Siegfried Weiss; Christian Bogdan; Ralph Goethe
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

5.  The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections.

Authors:  Thorsten Meißner; Elke Eckelt; Tina Basler; Jochen Meens; Julia Heinzmann; Abdulhadi Suwandi; Walter M R Oelemann; Sandra Trenkamp; Otto Holst; Siegfried Weiss; Boyke Bunk; Cathrin Spröer; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Cell Infect Microbiol       Date:  2014-08-14       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.